Battle brews over next-gen gene-editing tools; Eli Lilly cuts prices for some insulin products

The next CRISPR gene-editing patent war might look different; it's shaping up to be a free-for-all among a multitude of companies and labs.

March 1, 2023 Check out STAT+

Sponsored By

Maria Fabrizio for STAT STAT+ | CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools The ultimate winner might not be who invented the gene editing technology, but whoever uses it to make the best drug the fastest. By Jason Mast and Allison DeAngelis and Megan Molteni Eli Lilly cuts prices for some insulin products, but some are wary David Ricks, Eli Lilly's chairman and CEO, presented the moves as the latest bid by the company to work within a broken system. By Matthew Herper and Ed Silverman STAT+ | Facebook, TikTok, and proteins: Why big tech companies are betting on AI protein design From Meta to Salesforce to ByteDance, nearly every tech company is studying artificial intelligence's power to design proteins. By Brittany Trang Rebecca Blackwell/AP Covid-19 surveillance added new burdens on essential workers — and gave them little data to protect their health Covid-19 surveillance technologies added new burdens on essential workers — and gave them little data to protect their health. By Ambar Castillo Vote now in STAT Madness 2023 Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school's pioneering research. Then pick your favorites. Help us crown a champ! By STAT Staff Opinion: HHS's Environmental Justice Index institutionalizes climate apartheid The Environmental Justice Index announced by HHS will do many things — except provide environmental justice. By David Introcaso

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser